Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment

Italian Journal of Pediatrics

Maria Circelli³  Leonardo Fioravanti¹  Roberto Ravasio²  Carlo Dani¹ 

[1] Department of Neurosciences, Psychology, Drug Research and Child Health, Division of Neonatology, Careggi University Hospital of Florence, Florence, Italy;PHarmES sas, Studi di valutazione economica, Milano, Italy;Chiesi Farmaceutici, Via Palermo 26/A, 43122 Parma, Italy

关键词: Preterm infants;    Cost-effectiveness;    nCPAP;    RDS;    Surfactant;   

Others  :  802433
DOI  :  10.1186/1824-7288-40-40

 received in 2014-01-16, accepted in 2014-04-25,  发布年份 2014

【 摘 要 】

Background

The best criteria for surfactant treatment in the perinatal period are unknown and this makes it of interest to consider the possible economic implications of lessening the use of more restrictive criteria.

Objective

The objective of this study is the evaluation of the costs of respiratory care for preterm infants with Respiratory Distress Syndrome (RDS) treated with "early rescue" surfactant compared to a "late rescue" strategy.

Methods

The study was carried out applying the costs of materials used, of staff and pharmacological therapy calculated in the Neonatal Intensive Care Unit (NICU) of an Italian hospital to the Verder et al. study (Pediatrics 1999) clinical data.

Results

The cost for patients treated with early strategy was slightly lower than for patients treated with late strategy (Euro 4,901.70 vs. Euro 4,960.07). The cost of treatment with surfactant was greater in the early group (Euro 458.49 vs. Euro 311.74), but this was compensated by the greater cost of treatment with Mechanical Ventilation (MV) in the late group (respectively Euro 108.85 vs. Euro 259.25).

Conclusions

The cost-effectiveness analysis performed in this study shows how early treatment with surfactant in preterm infants with RDS, as well as being clinically more effective, is associated with a slightly lower cost.

【 授权许可】

   
2014 Dani et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Ho JJ, Henderson-Smart DJ, Davis PG: Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002, 2:CD002975.
• [2]Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH: Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev 2002, 4:CD002770.
• [3]Attar MA, Donn SM: Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol 2002, 7:353-360.
• [4]Stevens TP, Blennow M, Soll RF: Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev 2002, 2:CD003063.
• [5]De Klerk AM, De Klerk RK: Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health 2001, 37:161-167.
• [6]Gittermann MK, Fusch C, Gittermann AR, Regazzoni BM, Moessinger AC: Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants. Eur J Pediatr 1997, 156:384-388.
• [7]Polin RA, Sahni R: Newer experience with CPAP. Semin Neonatol 2002, 7:379-389.
• [8]Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB: Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008, 358:700-708.
• [9]Sandri F, Plavka R, Simeoni U: CURPAP Advisory Board: The CURPAP Study: an international randomized controlled trial to evaluate the efficacy of combining prophylactic surfactant and early nasal continuous positive pressure in very preterm infants. Neonatology 2008, 94:60-62.
• [10]Dunn MS, Kaempf J, Klerk de A, Klerk de R, Reilly M, Howard D, Ferrelli K, O’Conor J, Soll RF: Vermont Oxford Network DRM Study Group: randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011, 128:e1069-1076.
• [11]SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network: Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010, 362:1970-1979.
• [12]Rojas-Reyes MX, Morley CJ, Soll R: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012., 14CD000510
• [13]Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, Agertoft L, Djernes B, Nathan E, Reinholdt J: Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics 1999, 103:e24.
• [14]Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Vento M, Halliday HL: European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants–2013 update. Neonatology 2013, 103:353-368.
• [15]Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. Oxford: Oxford University Press; 2005.
• [16]Gruppo di lavoro AIES: Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia. PharmacoEconomics - Italian Research Articles 2009, 11:83-93.
• [17]GRIAC (Gruppo di Ricerca Infermieristica in Area Critica): Sistema CLOC: un percorso per la pianificazione dell’assistenza infermieristica e la determinazione del fabbisogno del personale. Milano: McGraw-Hill Libri Italia; 1998:91,93,98,164.
• [18]The OSIRIS Collaborative Group: Early versus delayed neonatal administration of a synthetic surfactant: the judgement of OSIRIS. Lancet 1992, 340:1363-1369.
• [19]European Exosurf Study Group: Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation: a European double-blind trial with sequential analysis. Online J Curr Clin Trials 1992., 10Doc. No. 28
• [20]Konishi M, Fujiwara T, Chida S, Maeta H, Shimada S, Kasai T, Fujii Y, Murakami Y: A prospective, randomized trial of early versus late administration of a single dose of surfactant-TA. Early Hum Dev 1992, 29:275-282.
• [21]Gortner L, Wauer RR, Hammer H, Stock GJ, Heitmann F, Reiter HL, Kühl PG, Möller JC, Friedrich HJ, Reiss I, Hentschel R, Jorch G, Hieronimi G, Kuhls E: Early versus late surfactant treatment in preterm infants of 27 to 32 weeks’ gestational age: a multicenter controlled clinical trial. Pediatrics 1998, 102:1153-1160.
• [22]Plavka R, Kopecký P, Sebron V, Svihovec P, Zlatohlávková B, Janus V: A prospective randomized comparison of conventional mechanical ventilation and very early high frequency oscillatory ventilation in extremely premature newborns with respiratory distress syndrome. Intensive Care Med 1999, 25:68-75.
• [23]Dani C, Bresci C, Lista G, Martano C, Messina F, Migliori C, Vento G: Neonatal respiratory support strategies in the intensive care unit: an Italian survey. Eur J Pediatr 2013, 172:331-336.